ATE fundamentals
An in-depth look to ANTIBE THERAPEUTICS INC operating, investing, and financing activities
ATE free cash flow for Q3 23 is -3.85 M CAD. For 2022, ATE free cash flow was -16.31 M CAD and operating cash flow was -16.3 M CAD.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CAD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM